16
Printed publications, namely, brochures, booklets, and
teaching materials in the field of psychedelic research,
psychotherapeutic treatments and therapies, mdma therapies,
medical marijuana, lsd-assisted psychotherapy,
ibogaine-assisted treatment, ayahuasca-assisted therapy,
mental health care and mental well-being, psychedelic
substances and science
35
Database management; online retail and pop-up retail stores
featuring manuals and guides in the field of science, video
recordings, jewelry, clothing, art, books, guides, water
bottles, computer accessories and artifacts; providing
independent review of clinical trials for business purposes;
promoting the interests of ptsd patients and their families
by means of public advocacy (term considered too vague by
the International Bureau - Rule 13 (2) (b) of the
Regulations); promoting public awareness of psychedelic
research, psychotherapeutic treatments and therapies, mdma
therapies, medical marijuana, lsd-assisted psychotherapy,
ibogaine-assisted treatment, ayahuasca-assisted therapy,
mental health care and mental well-being by means of public
advocacy (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations)
36
Accepting and administering monetary charitable
contributions; accepting and administering monetary
charitable contributions to fund medical research;
charitable fundraising
41
Educational services, namely, providing trainings on
psychedelic research, psychotherapeutic treatments and
therapies, mdma therapies, medical marijuana, lsd-assisted
psychotherapy, ibogaine-assisted treatment,
ayahuasca-assisted therapy, mental health care and mental
well-being and distributing printed educational materials in
connection therewith; educational services, namely,
providing trainings on mental health care and mental
well-being and distributing printed educational materials in
connection therewith; educational services, namely,
conducting workshops, seminars, trainings and conferences in
the fields of mental health and wellness, mental wellbeing,
mind-altering substances and science and distributing
printed educational materials in connection therewith;
on-line electronic newsletters delivered by e-mail in the
fields of psychedelic research, psychotherapeutic treatments
and therapies, mdma therapies, medical marijuana,
lsd-assisted psychotherapy, ibogaine-assisted treatment,
ayahuasca-assisted therapy, mental health care and mental
well-being, mind-altering substances and science (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); on-line library services,
namely, providing electronic library services which feature
newspapers, research articles, magazines, photographs and
pictures via an on-line computer network; online
non-downloadable periodicals in the nature of bulletins and
newsletters in the fields of psychedelic research,
psychotherapeutic treatments and therapies, mdma therapies,
medical marijuana, lsd-assisted psychotherapy,
ibogaine-assisted treatment, ayahuasca-assisted therapy,
mental health care and mental well-being, mind-altering
substances and science and psychedelic harm reduction (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); entertainment services, namely,
providing podcasts in the field of psychedelic research,
psychotherapeutic treatments and therapies, mdma therapies,
medical marijuana, lsd-assisted psychotherapy,
ibogaine-assisted treatment, ayahuasca-assisted therapy,
mental health care and mental well-being, mind-altering
substances and science and psychedelic harm reduction (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); education services, namely,
providing non-downloadable webinars in the field of
psychedelic research, psychotherapeutic treatments and
therapies, mdma therapies, medical marijuana, lsd-assisted
psychotherapy, ibogaine-assisted treatment,
ayahuasca-assisted therapy, mental health care and mental
well-being, mind-altering substances and science and
psychedelic harm reduction; public educational events,
namely, providing conferences and seminars, public education
classes, and trainings and book signing events for
entertainment purposes, all in the field of psychedelic
research, psychotherapeutic treatments and therapies, mdma
therapies, medical marijuana, lsd-assisted psychotherapy,
ibogaine-assisted treatment, ayahuasca-assisted therapy,
mental health care and mental well-being, mind-altering
substances and science and psychedelic harm reduction; none
of the foregoing involving possession, distribution or
dispensing of controlled substances
44
Providing an online computer database featuring information
about mental health professionals and mental health care
facilities (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations); providing an
on-line computer database featuring information, articles
and links in the field of psychotherapeutic treatments,
mdma- and other psychedelic-assisted therapies, treatment of
diseases and disorders of the central nervous system and
mental health disorders (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen